核因子红色素-2-相关因子2激活剂在管理Covid-19的可能作用
Hayder M Al-Kuraishy1, Ali I Al-Gareeb1, Omayma A Eldahshan2
1Department of Clinical Pharmacology and Medicine, College of Medicine, ALmustansiriyia University, Iraq.
核因子红色素2相关因子2 (Nrf2) 激活剂通过减少氧化应激和炎症,在控制COVID-19方面表现有前途. 建议进行进一步的研究,以探索Nrf2激活剂作为COVID-19管理的潜在治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 病理生理学 病理生理学
背景情况:
- 由SARS-CoV-2引起的COVID-19呈现出由氧化应激 (OS) 和高炎症驱动的肺和肺外症状.
- 严重的病例可能导致急性肺损伤 (ALI),急性呼吸困扰综合征 (ARDS),全身炎症和血栓事件.
研究的目的:
- 澄清核素红色素2相关因子2 (Nrf2) 激活剂在控制COVID-19中的潜在作用.
- 探索Nrf2在缓解SARS-CoV-2引起的并发症方面的机制.
主要方法:
- 审查有关SARS-CoV-2病理生理学和Nrf2信号通路的现有文献.
- 分析Nrf2在平衡OS和炎症中的作用.
主要成果:
- Nrf2激活减轻了SARS-CoV-2介导的病毒毒性和OS诱导的细胞损伤.
- Nrf2通路抑制了促炎性细胞因子表达和细胞因子风暴的发展.
- Nrf2激活剂可以减轻内皮功能障碍,RAS失调,免疫血栓形成和凝血病.
结论:
- Nrf2激活剂代表了COVID-19管理的潜在治疗策略.
- Nrf2激活剂可以通过抑制NLRP3炎症酶来减少SARS-CoV-2引起的炎症.
- 建议进行临床前和临床研究,以验证Nrf2激活剂用于COVID-19治疗.
更多相关视频
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
08:26A Simple and Efficient Method to Detect Nuclear Factor Activation in Human Neutrophils by Flow Cytometry
Published on: April 9, 2013
相关概念视频
Master Transcription Regulators
RNA Polymerase II Accessory Proteins
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Co-activators and Co-repressors
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
General Transcription Factors
